Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and ...

The biotherapeutics company said the treatment, LYT-200, is being evaluated in two ongoing clinical trials. It was previously granted orphan drug designation for the treatment of acute myeloid ...

These granules, available in 25 mg, 50 mg, and 75 mg per unit dose packets, are a generic equivalent of Kalydeco Oral ...

Johnson & Johnson has won Food and Drug Administration priority review for its application seeking approval of nipocalimab in certain patients with generalized myasthenia gravis.

With a decade-long collaboration history, the companies have previously demonstrated the value of their combined analysis ...

A new drug developed by Loyal, a San Francisco-based biotech company, is being tested in a clinical trial that will involve 1 ...

Gone are the days when Americans would criticize eggs for bad cholesterol. The FDA has put its stamp of approval for kids to ...

A Washington state-based nonprofit has launched a program training pharmacists to prescribe abortion medications via ...

Reforming patent litigation to mirror successful outcomes across Europe could significantly accelerate US biosimilar market ...

The Food and Drugs Authority (FDA) has issued a critical warning to the public regarding a fraudulent scheme in which ...

The condition, which is not contagious, usually appears in warm, wet parts of the body, such as armpits, under the breast, ...